START Madrid - Hospital Fundacion Jimenez Diaz

Madrid 28040

2 studies enrolling now · 2 studies all time

What they study most

ALK-Positive Large B-Cell Lymphoma, Advanced Breast Cancer, Breast Cancer, Burkitt Lymphoma, Chronic Lymphocytic Leukemia, DLBCL, DLBCL Germinal Center B-Cell Type, Duodenal-Type Follicular Lymphoma, EBV-Positive DLBCL, Nos, Follicular Lymphoma, HER2-negative Breast Cancer, HHV8-Positive DLBCL, Nos

Studies at this site

• Study of SGR-1505 in Mature B-Cell Neoplasms — Recruiting now
• First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer — Recruiting now